Editorial

You have full text access to this OnlineOpen article

Progression-free survival as a surrogate marker of overall survival†

Is it the good question?

  1. Bernard Escudier MD‡,*

Article first published online: 1 FEB 2011

DOI: 10.1002/cncr.25955

Issue

Cancer

Cancer

Volume 117, Issue 12, pages 2586–2587, 15 June 2011

Additional Information

How to Cite

Escudier, B. (2011), Progression-free survival as a surrogate marker of overall survival. Cancer, 117: 2586–2587. doi: 10.1002/cncr.25955

Author Information

  1. Department of Medical Oncology, Institut Gustave Roussy, Villejuif, France

  1. ‡

    Fax: (011) 33142115211

*Department of Medical Oncology, Institut Gustave-Roussy, 114 rue Edouard Vaillant, 94805 Villejuif, France

  1. †

    See original referenced article on pages 2637–42, this issue.

  2. ‡

    Fax: (011) 33142115211

Publication History

  1. Issue published online: 7 JUN 2011
  2. Article first published online: 1 FEB 2011
  3. Manuscript Accepted: 3 JAN 2011
  4. Manuscript Revised: 30 DEC 2010
  5. Manuscript Received: 7 DEC 2010

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (59K)

The use of progression-free survival as a surrogate marker of efficacy in cancer treatment has been the subject of much discussion in recent years. However, it should not be considered a surrogate marker for overall survival.

View Full Article (HTML) Get PDF (59K)